Press Release: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025

Dow Jones01-02 21:00

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--January 02, 2025-- 

Johnson & Johnson $(JNJ)$ today announced that its Board of Directors has declared a cash dividend for the first quarter of 2025 of $1.24 per share on the company's common stock. The dividend is payable on March 4, 2025 to shareholders of record at the close of business on February 18, 2025. The ex-dividend date is February 18, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250102880411/en/

 
    CONTACT:    Media contact: 

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

 
 

(END) Dow Jones Newswires

January 02, 2025 08:00 ET (13:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment